2.70
price up icon4.65%   0.12
after-market Handel nachbörslich: 2.75 0.05 +1.85%
loading
Schlusskurs vom Vortag:
$2.58
Offen:
$2.53
24-Stunden-Volumen:
1.80M
Relative Volume:
1.19
Marktkapitalisierung:
$466.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.70M
KGV:
-8.1818
EPS:
-0.33
Netto-Cashflow:
$-51.36M
1W Leistung:
-1.46%
1M Leistung:
+12.97%
6M Leistung:
-4.59%
1J Leistung:
-34.78%
1-Tages-Spanne:
Value
$2.43
$2.84
1-Wochen-Bereich:
Value
$2.43
$2.84
52-Wochen-Spanne:
Value
$1.89
$4.70

Savara Inc Stock (SVRA) Company Profile

Name
Firmenname
Savara Inc
Name
Telefon
51285113796
Name
Adresse
6836 BEE CAVE ROAD, AUSTIN, TX
Name
Mitarbeiter
59
Name
Twitter
@SavaraPharma
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
SVRA's Discussions on Twitter

Vergleichen Sie SVRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SVRA
Savara Inc
2.70 466.66M 0 -54.70M -51.36M -0.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.92 96.01B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.55 57.86B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.52 57.02B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
646.60 39.10B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.51 34.45B 3.81B -644.79M -669.77M -6.24

Savara Inc Stock (SVRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-29 Herabstufung H.C. Wainwright Buy → Neutral
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-11-13 Herabstufung Evercore ISI Outperform → In-line
2024-02-15 Eingeleitet JMP Securities Mkt Outperform
2023-11-07 Eingeleitet Guggenheim Buy
2023-05-16 Hochstufung Jefferies Hold → Buy
2023-03-31 Herabstufung Jefferies Buy → Hold
2021-03-16 Eingeleitet Piper Sandler Overweight
2021-03-15 Eingeleitet Oppenheimer Outperform
2019-06-13 Bestätigt H.C. Wainwright Buy
2019-06-13 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2019-06-13 Herabstufung Ladenburg Thalmann Buy → Neutral
2018-08-13 Fortgesetzt ROTH Capital Neutral
2018-01-03 Eingeleitet Ladenburg Thalmann Buy
2017-09-27 Fortgesetzt ROTH Capital Buy
2017-09-22 Eingeleitet Jefferies Buy
2017-09-11 Eingeleitet JMP Securities Mkt Outperform
Alle ansehen

Savara Inc Aktie (SVRA) Neueste Nachrichten

pulisher
09:08 AM

Savara Inc reports results for the quarter ended June 30Earnings Summary - TradingView

09:08 AM
pulisher
08:06 AM

Savara Reports Second Quarter 2025 Financial Results and Provides a Business Update - itemonline.com

08:06 AM
pulisher
Aug 12, 2025

What machine learning models say about Savara Inc.Reversal Signal Prediction Based on Volume - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Can a trend reversal in Savara Inc. lead to recoveryFree AI Based High Gain Watchlist Scanner - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

How Savara Inc. stock performs during market volatilityReal-Time Equity Price Action Analysis - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Is Savara Inc. forming bullish engulfing patternsHigh Momentum Profit Stocks - thegnnews.com

Aug 10, 2025
pulisher
Aug 08, 2025

Savara Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Savara Inc.’s Price Action Aligns with Quant SignalsCommunity Verified Stock Suggestions Drive Volume - metal.it

Aug 08, 2025
pulisher
Aug 06, 2025

Why Savara Inc. stock attracts strong analyst attentionFree Conservative Long Term Growth Plans - Newser

Aug 06, 2025
pulisher
Aug 04, 2025

Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 - MSN

Aug 04, 2025
pulisher
Aug 03, 2025

Is Savara Inc. stock overvalued or undervaluedSuperior capital gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Savara Inc. company’s key revenue driversOverwhelming financial success - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What markets is WTBA expanding into Is Savara Inc. stock a good long term investment option - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Savara Inc. stock expected to show significant growthFree Stock Selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Savara Inc. stock price move sharplySky-high return potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Savara Inc. generate profit in a changing economyCapitalize on emerging investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Savara Inc. stock perform well during market downturnsFree Risk Assessment Services - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Savara Inc. stock attracting strong analyst attentionRapid growth trajectories - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Savara Inc. in the next 12 monthsFree AI-Backed Trading Signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate Savara Inc. as a “Buy”Consistent triple-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Oppenheimer Assumes Coverage of Savara (SVRA) With an Outperform Rating - MSN

Aug 02, 2025
pulisher
Aug 01, 2025

What are the latest earnings results for Savara Inc.Retirement Planning Signals To Watch Now - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

Is Savara Inc. a growth stock or a value stockPre Market Forecasts For Beginners - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey

Jul 31, 2025
pulisher
Jul 30, 2025

Heatmap Data Shows High Activity in Savara Inc. SectorAI Screening for Swing Trade Picks Finds Momentum - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Recovery Setup Building in Savara Inc. Experts SayEntry Plan for Oversold Reversal Stocks Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Great Week for Savara Inc. (NASDAQ:SVRA) Institutional Investors After Losing 42% Over the Previous Year - 富途牛牛

Jul 29, 2025
pulisher
Jul 29, 2025

What technical models suggest about Savara Inc.’s comebackStock Portfolio Risk and Return Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Using flow based indicators on Savara Inc.Free Community Entry Consensus Trade Ideas - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Real time pattern detection on Savara Inc. stockFree Buy Low Sell High Stock Watch - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Savara (SVRA.O) Surges 5.6%: Uncovering the Hidden Drivers Behind the Intraday Spike - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Savara Inc. stockBuild wealth faster with expert stock selection - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Will Savara Inc. outperform the marketFree Growth Based Investment Plan Guidance - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Using flow based indicators on Savara Inc. Trade Safety Matrix for Conservative Traders - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Heatmap analysis for Savara Inc. and competitors Downside Control Plan With Support Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What recovery options are there for Savara Inc. Free Market Surge Signal for Swing Traders - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Savara Inc.Market Forecast Planner With Proven Results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is Savara Inc. company’s growth strategyFree Stock Market Return Analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Will Savara Inc. Stock Benefit from AI and Green Energy TrendsCapital Safe Smart Trades - metal.it

Jul 27, 2025

Finanzdaten der Savara Inc-Aktie (SVRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Savara Inc-Aktie (SVRA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
McCracken Joseph S
Director
May 29 '25
Buy
2.08
10,000
20,825
260,837
RAMSAY DAVID A
Director
Mar 31 '25
Buy
2.77
150,000
416,250
2,513,642
Lowrance David L
Chief Financial Officer
Dec 16 '24
Sale
3.33
25,000
83,278
381,005
Pauls Matthew
CHIEF EXECUTIVE OFFICER
Dec 16 '24
Sale
3.31
54,702
180,828
1,536,379
Hawkins Richard J
Director
Dec 16 '24
Sale
3.32
8,000
26,569
67,241
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
Kapitalisierung:     |  Volumen (24h):